New diabetes research center to be established in Berne
Work on setting up a diabetes research center in Berne is already to start this year. The focus of the Diabetes Center B…
Work on setting up a diabetes research center in Berne is already to start this year. The focus of the Diabetes Center B…
The human insulin of Russian pharmaceutical company GEROPHARM will in future be administered with a pen from Ypsomed's S…
The shareholders of Ypsomed Holding AG approved all proposals by the board of directors by a large majority at the regul…
In the business year 2015/16, the Ypsomed Group generated consolidated sales totaling CHF 336.9 million (prior year: CHF…
The reusable and affordable YpsoPen® is becoming more and more popu-lar. In the coming weeks, it will be supplied to Ukr…
Ypsomed Group and the Chinese pharmaceutical company Tonghua Dongbao Pharmaceutical Co., Ltd. have further intensified t…
The shareholders of Ypsomed Holding AG approved all proposals by the board of directors by a large majority at the regul…
Ypsomed now supplies the Polish company Polfa Tarchomin S. A. with its reusable and affordable YpsoPen®. The YpsoPen® is…
In business year 2014/15 Ypsomed Group posted consolidated sales of CHF 306.6 million, which represents an increase of 1…
The criterion for inclusion in the Swiss Performance Index (SPI) - a minimum free float of Ypsomed registered shares of…